# Growth Hormone to Increase Immune Function in People With HIV

> **NCT00071240** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 22 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Somatropin (recombinant human growth hormone)

## Key facts

- **NCT ID:** NCT00071240
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2009-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071240, "Growth Hormone to Increase Immune Function in People With HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00071240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*